Supernus Pharma (SUPN) Receives Sixth U.S. Patent Related to Oxtellar XR
Tweet Send to a Friend
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) announced the issuance on May 31, 2016 of a sixth patent (number 9,351,975) by the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
